| Typicality: | 0.391 |
| Saliency: | 0.338 |
| frequently | 17 | temporal |
| according to the fda | 3 | other |
| in 22% of patients | 2 | other |
| drug → cause → serious adverse effects | 22 |
| drug → cause → serious adverse health consequences | 6 |
| drug → cause → serious adverse events | 4 |
| drug → cause → severe adverse effects | 3 |
| drug → cause → serious effects | 3 |
| negative | neutral | positive |
| 0.761 | 0.205 | 0.034 |
| Raw frequency | 38 |
| Normalized frequency | 0.338 |
| Modifier score | 0.759 |
| Perplexity | 47.123 |